|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 707 studies with search of: | "Thrombosis" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
|
||||
| 2 | Recruiting |
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
|
||||
| 3 | Recruiting |
Rosuvastatin for Preventing Deep Vein Thrombosis
|
||||
| 4 | Completed |
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
|
||||
| 5 | Active, not recruiting |
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
|
||||
| 6 | Completed |
Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis (ODIXa-DVT)
|
||||
| 7 | Recruiting |
Study in an Ex-vivo Thrombosis Model With Human Umbilical Vein Endothelial Cells (HUVEC)-Perfusion
|
||||
| 8 | Terminated |
Anticoagulation Post Laparoscopic Splenectomy
|
||||
| 9 | Not yet recruiting |
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots
|
||||
| 10 | Recruiting |
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
|
||||
| 11 | Completed |
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
|
||||
| 12 | Completed |
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
|
||||
| 13 | Completed |
Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
|
||||
| 14 | Completed |
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
|
||||
| 15 | Active, not recruiting |
Treatment of Upper Extremity Deep-Vein Thrombosis
|
||||
| 16 | Recruiting |
Usefulness of Anticoagulant Treatment in First Isolated Symptomatic Calf Vein Thrombosis
|
||||
| 17 | Completed |
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
|
||||
| 18 | Enrolling by invitation |
Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis
|
||||
| 19 | Not yet recruiting |
Usefulness of Anticoagulant Treatment in Isolated Symptomatic Calf Vein Thrombosis.
|
||||
| 20 | Completed |
VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|